MyFinsight
Home
About
Contact
Back
Income Statement
Lyell Immunopharma, Inc. (LYEL)
source: myfinsight.com
Download
Download image
Comprehensive loss
-$42,785K
(6.59%↑ Y/Y)
Interest income, net
$3,276K
(-48.52%↓ Y/Y)
Other income
(expense), net
$1,180K
(282.95%↑ Y/Y)
Net loss
-$42,684K
(6.82%↑ Y/Y)
Net unrealized
(loss) gain on...
-$101K
(-1542.86%↓ Y/Y)
Total other income,
net
$4,456K
(-22.08%↓ Y/Y)
Loss from operations
-$47,140K
(8.52%↑ Y/Y)
Revenue
$8K
(-38.46%↓ Y/Y)
Total operating
expenses
$47,148K
(-8.52%↓ Y/Y)
General and
administrative
$9,786K
(-20.15%↓ Y/Y)
Impairment of long-lived
assets
$1,443K
Other operating loss
(income), net
-$1,062K
(-208.81%↓ Y/Y)
Research and development
$34,857K
(-13.42%↓ Y/Y)
Back